EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: A case-control study of overall survival

Faehling, M.; Eckert, R.; Kamp, T.; Kuom, S.; Griese, U.; Straeter, J.; Ott, G.; Spengler, W.

dc.contributor.author	Spengler, Werner
dc.date.accessioned	2013-12-09T10:01:04Z
dc.date.available	2013-12-09T10:01:04Z
dc.date.issued	2013
dc.identifier.issn	0169-5002
dc.identifier.uri	http://hdl.handle.net/10900/39141
dc.language.iso	en	en
dc.publisher	Elsevier Ireland Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.lungcan.2013.02.010	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	EGFR-tyrosine kinase inhibitor treatment beyond progression in long-term Caucasian responders to erlotinib in advanced non-small cell lung cancer: A case-control study of overall survival	de_DE
dc.type	Article	de_DE
utue.quellen.id	20130911224530_00644	de_DE
utue.publikation.seiten	306-312	de_DE
utue.personen.roh	Faehling, M.
utue.personen.roh	Eckert, R.
utue.personen.roh	Kamp, T.
utue.personen.roh	Kuom, S.
utue.personen.roh	Griese, U.
utue.personen.roh	Straeter, J.
utue.personen.roh	Ott, G.
utue.personen.roh	Spengler, W.
dcterms.isPartOf.ZSTitelID	Lung Cancer	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	80	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE